N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
Details for Australian Patent Application No. 2002338334 (hide)
International Classifications
Event Publications
20 February 2003 Complete Application Filed
Priority application(s): 60/281,166 03.04.01 US
10 April 2003 Application Open to Public Inspection
Published as AU-B-2002338334
14 August 2008 Application Accepted
Published as AU-B-2002338334
18 September 2008 Corrigenda
Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2002338334, under INID(72), correct the co-inventors names to McCauley, James A. and McIntyre, Charles J.
9 October 2008 Corrigenda
Applications Accepted - Name Index Under the name Merck & Co., Inc., Application No. 2002338334, under INID(72), correct the co inventor name McCauley, John A.
11 December 2008 Standard Patent Sealed
28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002338335-TWO STEP PUNCTURING AND VENTING OF SINGLE SERVE FILTER CARTRIDGE IN A BEVERAGE BREWER
2002338333-METHODS FOR TREATING HYPERACTIVE GASTRIC MOTILITY
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser